Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Cash from Investing Activities (2021 - 2025)

Cingulate's (CING) quarterly Cash from Investing Activities came in at -$156213.0 in Q4 2025, up 21.29% on a YoY basis from -$128794.9 in Q4 2024, and up 21.29% quarter-over-quarter from -$198462.0 in Q4 2024.

Analysis

Cingulate (CING) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Cingulate (CING) has reported Cash from Investing Activities for 5 consecutive years, with -$156213.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 21.29% year-over-year to -$156213.0; the trailing twelve-month figure through Dec 2025 stood at -$213880.0 (down 0.98% YoY), and the FY2025 full-year result was -$162138.0, up 23.45% from the prior year.
  • Cash from Investing Activities grew to -$156213.0 in Q4 2025 per CING's latest filing, from -$198462.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $140795.0 in Q3 2024 and bottomed at -$710007.0 in Q4 2021.
  • Historically, Cash from Investing Activities has averaged -$97468.6 across 5 years, with a median of -$51802.0 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities surged 120.6% in 2022, then tumbled 7262400.0% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$710007.0 in 2021, then jumped by 79.86% to -$143020.0 in 2022, then sank by 30.72% to -$186960.0 in 2023, then declined by 6.15% to -$198462.0 in 2024, then increased by 21.29% to -$156213.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$156213.0, -$198462.0, and $140795.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -1.11 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -1.20 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -3.11 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 2.11 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -1.61 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -424.26 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -1.66 Bn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -49.35 Mn
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -156,213.00
Dec 31, 2024 -198,462.00
Sep 30, 2024 140,795.00
Jun 30, 2024 -72,625.00
Mar 31, 2024 -81,508.00
Dec 31, 2023 -186,960.00
Jun 30, 2023 -1.00
Mar 31, 2023 -37,135.00
Dec 31, 2022 -143,020.00
Sep 30, 2022 3,250.00
Jun 30, 2022 -2,482.00
Mar 31, 2022 -10,400.00
Dec 31, 2021 -710,007.00
Sep 30, 2021 -15,774.00
Jun 30, 2021 -22,486.00
Mar 31, 2021 -66,469.00
API Access

Cingulate Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CING&period=max&api_key=YOUR_API_KEY